IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VINGIANI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.040
AS - Asia 5.720
NA - Nord America 4.714
SA - Sud America 507
AF - Africa 140
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.174
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.539
DE - Germania 3.668
CN - Cina 1.832
SG - Singapore 1.615
IT - Italia 1.366
GB - Regno Unito 799
HK - Hong Kong 550
RU - Federazione Russa 453
BR - Brasile 383
BD - Bangladesh 374
IN - India 354
VN - Vietnam 313
SE - Svezia 277
NL - Olanda 270
FR - Francia 263
LT - Lituania 207
JP - Giappone 154
FI - Finlandia 133
CA - Canada 107
ID - Indonesia 105
IE - Irlanda 97
TR - Turchia 87
KR - Corea 84
ES - Italia 82
BE - Belgio 64
DK - Danimarca 58
PL - Polonia 54
AU - Australia 43
CH - Svizzera 40
AT - Austria 39
MX - Messico 39
PH - Filippine 39
AR - Argentina 36
CI - Costa d'Avorio 36
ZA - Sudafrica 29
NO - Norvegia 28
EC - Ecuador 24
IQ - Iraq 24
RO - Romania 23
UA - Ucraina 22
PK - Pakistan 19
PT - Portogallo 18
TW - Taiwan 18
GR - Grecia 17
IL - Israele 17
SA - Arabia Saudita 15
CZ - Repubblica Ceca 14
KE - Kenya 14
VE - Venezuela 14
CO - Colombia 13
UZ - Uzbekistan 13
EG - Egitto 12
JO - Giordania 12
PE - Perù 12
MY - Malesia 11
CL - Cile 10
DZ - Algeria 10
IR - Iran 10
MA - Marocco 10
AE - Emirati Arabi Uniti 9
TH - Thailandia 9
TN - Tunisia 9
LV - Lettonia 8
KG - Kirghizistan 7
NP - Nepal 7
AZ - Azerbaigian 6
BA - Bosnia-Erzegovina 6
JM - Giamaica 6
NZ - Nuova Zelanda 6
SC - Seychelles 6
UY - Uruguay 6
AL - Albania 5
CY - Cipro 5
IS - Islanda 5
OM - Oman 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
HR - Croazia 4
HU - Ungheria 4
MO - Macao, regione amministrativa speciale della Cina 4
NG - Nigeria 4
PS - Palestinian Territory 4
BO - Bolivia 3
CR - Costa Rica 3
EU - Europa 3
GT - Guatemala 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
MD - Moldavia 3
NI - Nicaragua 3
PY - Paraguay 3
RS - Serbia 3
AM - Armenia 2
CM - Camerun 2
ET - Etiopia 2
GE - Georgia 2
GY - Guiana 2
LK - Sri Lanka 2
Totale 19.152
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 3.308
Singapore 823
Ashburn 659
Southend 608
Milan 478
Hong Kong 475
Dallas 470
San Jose 361
Beijing 258
Hefei 251
Chandler 213
Council Bluffs 174
Los Angeles 153
Santa Clara 137
Bengaluru 120
New York 120
Vilnius 109
Wilmington 101
Ho Chi Minh City 96
Dublin 95
Guangzhou 91
Shanghai 90
Fairfield 89
Rome 86
Helsinki 85
Lauterbourg 84
Moscow 83
Buffalo 77
Hanoi 75
Jakarta 72
Princeton 72
Seattle 72
Houston 70
Tokyo 64
Dearborn 62
Munich 59
Ann Arbor 56
Amsterdam 55
Boardman 54
Istanbul 53
Nuremberg 53
Nanjing 50
São Paulo 47
Cambridge 45
Seoul 45
Hyderabad 44
Grafing 37
Abidjan 36
Woodbridge 36
Kaunas 34
Toronto 34
Chicago 33
London 33
Columbus 32
Hangzhou 32
Shenyang 32
Brussels 31
Cangzhou 31
Redwood City 30
Des Moines 29
Phoenix 29
San Diego 29
Hanover 28
Berlin 26
Klaipėda 26
St Petersburg 26
Jinan 25
Tianjin 25
Turku 24
Atlanta 23
The Dalles 23
Boston 20
Pune 20
Turin 20
Vienna 20
Florence 19
Naples 19
Chennai 18
Orem 18
Fuzhou 17
Warsaw 17
Wuhan 17
Zhengzhou 17
Bologna 15
Fremont 15
Genoa 15
Shenzhen 15
Delft 14
Falls Church 14
Manchester 14
Montreal 14
Silver Spring 14
Sydney 14
Washington 14
Barcelona 13
Bucharest 13
Johannesburg 13
Lappeenranta 13
Madrid 13
Mumbai 13
Totale 11.944
Salva come PNG Salva come JPEG
Nome #
Adding fasting-mimicking diet to first-line carboplatin-based chemotherapy is associated with better overall survival in advanced triple-negative breast cancer patients: A subanalysis of the NCT03340935 trial 1.010
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors 843
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research 598
Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative 491
Transplantation of autologous extracellular vesicles for cancer-specific targeting 481
Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation 414
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence 347
Predictive role of CD36 expression in HER2-positive breast cancer patients receiving neoadjuvant trastuzumab 325
Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison 324
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials 323
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research 310
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer 300
A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high-grade serous ovarian cancer 294
Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma 285
The Stearoyl-CoA desaturase1 (SCD) in Drosophila is necessary for Myc induced autophagy, a potential new link to tumor growth 265
Macrophage morphology and distribution are strong predictors of prognosis in resected colorectal liver metastases: results from an external retrospective observational study 263
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series 259
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00 254
Towards mm-wave spectroscopy for dielectric characterization of breast surgical margins 251
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer 248
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 238
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 237
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy 234
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer 226
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer 224
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma 220
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial 220
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 219
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast 217
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients 217
Effect of metformin on breast ductal carcinoma in situ proliferation in a randomized presurgical trial 211
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model 208
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC) 206
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples 203
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors 198
Biomarkers for the identification of recurrence in human epidermal growth factor receptor 2-positive breast cancer patients 197
Oncological Outcomes of Nipple-Sparing Mastectomy : a Single-Center Experience of 1989 Patients 196
Immune and Gene-expression Profiling in Estrogen Receptor Low and Negative Early Breast Cancer 195
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/ metastatic head and neck squamous cell carcinoma treated with nivolumab 194
The clinical relevance of micropapillary carcinoma of the breast : a case-control study 187
Clinical outcomes and radio-biological features correlation in early pca: An exploratory analysis 186
Retroperitoneal pararenal isolated neuro fibroma: report of a case and review of literature 186
Contrast-enhanced mammography in the evaluation of breast calcifications: preliminary experience 184
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO 182
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer 181
Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study 177
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications 176
Innate immunity in colorectal liver metastases: macrophage morphology and distribution are strong predictors of prognosis: An external validation 169
Prognostic role of body mass index (BMI) in patients with Human Epidermal growth factor Receptor 2 (HER2)epositive early breast cancer treated with adjuvant trastuzumab-containing chemotherapy 168
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy 167
12P The RODILIA pilot study for molecular screening of patients with metaplastic breast cancer 166
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group 165
Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group 163
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors 162
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer 162
Mammographic density to predict response to neoadjuvant systemic breast cancer therapy 161
Analysis of Efficacy and Accuracy of 2 Vacuum-Assisted Breast Biopsy Devices: Mammotome and Elite 160
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer 157
A single-arm, open-label, multicenter, phase IIIb clinical trial with nivolumab in subjects with recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck 156
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors : a Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group : Part 1 : Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research 154
Pulmonary squamous cell carcinoma with lepidic growth pattern : new insights into lung cancer classification 153
Fatty acid uptake as a potentially new resistance mechanism to anti-HER2 treatments in HER2-positive breast cancer 152
Detection of genomically aberrant cells within circulating tumor microemboli (CTMs) isolated from early-stage breast cancer patients 151
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer 150
Acquired Resistance Mechanisms to PD-L1 Blockade in a Patient With Microsatellite Instability-High Extrahepatic Cholangiocarcinoma 150
Multidisciplinary management of pregnancy-associated and early post-partum head and neck cancer patients 144
The impact of COVID-19 on diagnosis of recurrent breast cancer 141
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast 140
Targeted-gene sequencing to catch triple negative breast cancer heterogeneity before and after neoadjuvant chemotherapy 140
Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells 139
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer 133
Primary tumor somatic mutations in the blood of women with ductal carcinoma in situ of the breast 132
Solitary thyroid metastasis from colon cancer: A rare case report 127
Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC) 122
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers 121
First report of AURORA, the breast international group (BIG) molecular screening initiative for metastatic breast cancer (MBC) patients (pts) 120
Malignant salivary gland tumours in families with breast cancer susceptibility 120
Ultra-deep multigene profiling of matched primary and metastatic hormone receptor positive breast cancer patients relapsed after adjuvant endocrine treatment reveals novel aberrations in the estrogen receptor pathway 119
Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer 119
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care 118
Mammographic density to predict response to neoadjuvant chemotherapy for breast cancer 116
Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities 116
Real-world use of multigene signatures in early breast cancer: differences to clinical trials 115
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer 112
Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer 112
Enhancers mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer 110
ROS1 Gene Fusion in Advanced Lung Cancer in Women : A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm 109
Salivary gland choristoma in large bowel 107
Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy 107
Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world 106
Early downmodulation of tumor glycolysis predicts response to fasting-mimicking diet in triple-negative breast cancer patients 77
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study 62
Timeline of surgery in localized angiosarcoma of the breast: Improving outcome following multidisciplinary treatment optimization 54
Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy 47
The pathology report 47
Tumor infiltrating lymphocytes in early breast cancer 42
Advancing breast cancer therapy in the era of molecular diagnostics 9
Part II - Analytical phase 8
null 4
null 3
Totale 19.668
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.340
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 0 0 0 0 0 66
2021/2022982 84 73 51 57 78 39 50 74 172 113 64 127
2022/20231.173 118 81 100 98 122 246 71 63 84 30 126 34
2023/20243.225 76 79 73 75 206 187 485 412 209 424 492 507
2024/20254.484 456 443 403 412 256 212 220 375 217 385 353 752
2025/20267.665 800 776 964 600 536 378 950 314 628 616 882 221
Totale 19.679